Protalix BioTherapeutics, Inc. (PLX) Current Reports & Earnings Releases
Upcoming
- 2026-11-12 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-25 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-21 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-18 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-09 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-02-11 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-30 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-05 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-03 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-17 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-22 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-01 | 8-K | Other Events | SEC |
| 2025-07-21 | 8-K | Material Agreement, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-06-26 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-23 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-03-17 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-17 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-31 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-12-23 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-25 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-28 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.